Sage Therapeutics announced interim, topline results from a July data cut of the ongoing Phase 3 open-label SHORELINE Study. This clinical study was designed to naturalistically follow patients with major depressive disorder (MDD) and evaluate the safety and...
Psychology
Category
Axsome Therapeutics Announces Topline Results of the STRIDE-1 Phase 3 Trial in Treatment Resistant Depression
Axsome Therapeutics announced top-line results from the phase 3 STRIDE-1 trial evaluating AXS-05 versus active comparator bupropion for treatment of treatment resistant depression (TRD). The trial met key secondary endpoints in the STRIDE-1 trial by rapidly and...
The Unclear Evidence of Evidence-Based Therapy in Psychology
Over the past decade, many scholars have questioned the credibility of research across a variety of scientific fields. Some of these concerns arise from cases of outright fraud or other misconduct. TrialSite News even covered one such story last...
FDA Approves Expanded Access Application for MDMA-Assisted Psychotherapy in PTSD Patients
The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced that the U.S. Food and Drug Administration (FDA) has agreed to MAPS’ application for an Expanded Access program for MDMA-assisted psychotherapy for posttraumatic stress disorder...
NYU School of Medicine Research Reveals AI Can Diagnose PTSD with Voice Analysis
New York University School of Medicine researchers are in hot pursuit of demonstrating how Artificial Intelligence (AI) can detect post-traumatic stress disorder (PTSD) in veterans by analyzing their voices. A recent study published in Depression and Anxiety and...